©2024 Stanford Medicine
Clinical Trials Contact
About this Clinical Trial
Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events
Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events